• 时尚资讯
  • 九块邮
  • 手机版
    • 最新折扣
    • 好券直播
    • 品牌券
    • 20封顶
    • 更多导航
      热门活动热门标签
    积分商城
    • 全部>“profile” 共766个商品
      • 默认
      • 销量
      • 价格
    • 预订 VELTASSA (patiromer sorbitex calcium) Drug Profile, 2025: VELTASSA (patiromer sorbitex calcium) drug patents, litig

      patiromerVELTASSAsorbitexcalcium

      预订 VELTASSA (patiromer sorbitex calcium) Drug Profile, 2025: VELTASSA (patiromer sorbitex calcium) drug patents, litig

      ¥3,026券后¥3,3260人已购买
      优惠券¥300 领券购买 
    • 预订 SUNOSI (solriamfetol hydrochloride) Drug Profile, 2025: SUNOSI (solriamfetol hydrochloride) drug patents, litigatio

      hydrochloridesolriamfetolSUNOSIDrug

      预订 SUNOSI (solriamfetol hydrochloride) Drug Profile, 2025: SUNOSI (solriamfetol hydrochloride) drug patents, litigatio

      ¥3,029券后¥3,3290人已购买
      优惠券¥300 领券购买 
    • 预订 STRIVERDI RESPIMAT (olodaterol hydrochloride) Drug Profile, 2025: STRIVERDI RESPIMAT (olodaterol hydrochloride) dru

      hydrochlorideolodaterolSTRIVERDIRESPIMAT

      预订 STRIVERDI RESPIMAT (olodaterol hydrochloride) Drug Profile, 2025: STRIVERDI RESPIMAT (olodaterol hydrochloride) dru

      ¥3,029券后¥3,3290人已购买
      优惠券¥300 领券购买 
    • 预订 TIBSOVO (ivosidenib) Drug Profile, 2025: TIBSOVO (ivosidenib) drug patents, litigation, PTAB cases, SPCs, clinical

      ivosidenibTIBSOVODruglitigation

      预订 TIBSOVO (ivosidenib) Drug Profile, 2025: TIBSOVO (ivosidenib) drug patents, litigation, PTAB cases, SPCs, clinical

      ¥3,029券后¥3,3290人已购买
      优惠券¥300 领券购买 
    • 预订 STEGLUJAN (ertugliflozin; sitagliptin phosphate) Drug Profile, 2025: STEGLUJAN (ertugliflozin; sitagliptin phosphat

      ertugliflozinsitagliptinSTEGLUJANphosphate

      预订 STEGLUJAN (ertugliflozin; sitagliptin phosphate) Drug Profile, 2025: STEGLUJAN (ertugliflozin; sitagliptin phosphat

      ¥3,029券后¥3,3290人已购买
      优惠券¥300 领券购买 
    • 预订 TRINTELLIX (vortioxetine hydrobromide) Drug Profile, 2025: drug patents, patent challenges, litigation, SPCs, clini

      DrugvortioxetinehydrobromideTRINTELLIX

      预订 TRINTELLIX (vortioxetine hydrobromide) Drug Profile, 2025: drug patents, patent challenges, litigation, SPCs, clini

      ¥3,030券后¥3,3300人已购买
      优惠券¥300 领券购买 
    • 预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      sacubitrilvalsartanENTRESTODrug

      预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      ¥3,030券后¥3,3300人已购买
      优惠券¥300 领券购买 
    • 预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      eluxadolineVIBERZIDruglitigation

      预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      ¥3,031券后¥3,3310人已购买
      优惠券¥300 领券购买 
    • 预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      larotrectinibVITRAKVIsulfateDrug

      预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      ¥3,032券后¥3,3320人已购买
      优惠券¥300 领券购买 
    • 预订 EPCLUSA (sofosbuvir; velpatasvir) Drug Profile, 2025: EPCLUSA (sofosbuvir; velpatasvir) drug patents, litigation, P

      velpatasvirsofosbuvirEPCLUSADrug

      预订 EPCLUSA (sofosbuvir; velpatasvir) Drug Profile, 2025: EPCLUSA (sofosbuvir; velpatasvir) drug patents, litigation, P

      ¥3,033券后¥3,3330人已购买
      优惠券¥300 领券购买 
    • 预订 TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: TRIUMEQ PD (abacavir sulfate; do

      abacavirTRIUMEQsulfatedolutegravir

      预订 TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: TRIUMEQ PD (abacavir sulfate; do

      ¥3,034券后¥3,3340人已购买
      优惠券¥300 领券购买 
    • 预订 NINLARO (ixazomib citrate) Drug Profile, 2025: NINLARO (ixazomib citrate) drug patents, litigation, SPCs, clinical

      ixazomibNINLAROcitrateDrug

      预订 NINLARO (ixazomib citrate) Drug Profile, 2025: NINLARO (ixazomib citrate) drug patents, litigation, SPCs, clinical

      ¥3,036券后¥3,3360人已购买
      优惠券¥300 领券购买 
    • 预订 TAZVERIK (tazemetostat hydrobromide) Drug Profile, 2025: TAZVERIK (tazemetostat hydrobromide) drug patents, clinica

      tazemetostathydrobromideTAZVERIKDrug

      预订 TAZVERIK (tazemetostat hydrobromide) Drug Profile, 2025: TAZVERIK (tazemetostat hydrobromide) drug patents, clinica

      ¥3,036券后¥3,3360人已购买
      优惠券¥300 领券购买 
    • 预订 TRIJARDY XR (empagliflozin; linagliptin; metformin hydrochloride) Drug Profile, 2025: TRIJARDY XR (empagliflozin; l

      empagliflozinTRIJARDYhydrochloridelinagliptin

      预订 TRIJARDY XR (empagliflozin; linagliptin; metformin hydrochloride) Drug Profile, 2025: TRIJARDY XR (empagliflozin; l

      ¥3,037券后¥3,3370人已购买
      优惠券¥300 领券购买 
    • 预订 TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: drug patents, patent challenges, li

      Drugdolutegravirlamivudinechallenges

      预订 TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: drug patents, patent challenges, li

      ¥3,038券后¥3,3380人已购买
      优惠券¥300 领券购买 
    • 预订 ANORO ELLIPTA (umeclidinium bromide; vilanterol trifenatate) Drug Profile, 2025: ANORO ELLIPTA (umeclidinium bromid

      umeclidiniumELLIPTAANOROtrifenatate

      预订 ANORO ELLIPTA (umeclidinium bromide; vilanterol trifenatate) Drug Profile, 2025: ANORO ELLIPTA (umeclidinium bromid

      ¥3,039券后¥3,3390人已购买
      优惠券¥300 领券购买 
    • 预订 CLENPIQ (citric acid; magnesium oxide; sodium picosulfate) Drug Profile, 2025: CLENPIQ (citric acid; magnesium oxid

      magnesiumCLENPIQcitricacid

      预订 CLENPIQ (citric acid; magnesium oxide; sodium picosulfate) Drug Profile, 2025: CLENPIQ (citric acid; magnesium oxid

      ¥3,040券后¥3,3400人已购买
      优惠券¥300 领券购买 
    • 预订 BRENZAVVY (bexagliflozin) Drug Profile, 2025: BRENZAVVY (bexagliflozin) drug patents, litigation, suppliers, API so

      bexagliflozinBRENZAVVYDruglitigation

      预订 BRENZAVVY (bexagliflozin) Drug Profile, 2025: BRENZAVVY (bexagliflozin) drug patents, litigation, suppliers, API so

      ¥3,041券后¥3,3410人已购买
      优惠券¥300 领券购买 
    • 预订 BONJESTA (doxylamine succinate; pyridoxine hydrochloride) Drug Profile, 2025: BONJESTA (doxylamine succinate; pyrid

      doxylaminesuccinateBONJESTAhydrochloride

      预订 BONJESTA (doxylamine succinate; pyridoxine hydrochloride) Drug Profile, 2025: BONJESTA (doxylamine succinate; pyrid

      ¥3,041券后¥3,3410人已购买
      优惠券¥300 领券购买 
    • 预订 EDARBYCLOR (azilsartan kamedoxomil; chlorthalidone) Drug Profile, 2025: EDARBYCLOR (azilsartan kamedoxomil; chlorth

      kamedoxomilEDARBYCLORazilsartanchlorthalidone

      预订 EDARBYCLOR (azilsartan kamedoxomil; chlorthalidone) Drug Profile, 2025: EDARBYCLOR (azilsartan kamedoxomil; chlorth

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 TAFINLAR (dabrafenib mesylate) Drug Profile, 2025: TAFINLAR (dabrafenib mesylate) drug patents, litigation, SPCs, c

      dabrafenibTAFINLARmesylateDrug

      预订 TAFINLAR (dabrafenib mesylate) Drug Profile, 2025: TAFINLAR (dabrafenib mesylate) drug patents, litigation, SPCs, c

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 CABTREO (adapalene; benzoyl peroxide; clindamycin phosphate) Drug Profile, 2025: CABTREO (adapalene; benzoyl peroxi

      adapaleneCABTREObenzoylclindamycin

      预订 CABTREO (adapalene; benzoyl peroxide; clindamycin phosphate) Drug Profile, 2025: CABTREO (adapalene; benzoyl peroxi

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 TAGRISSO (osimertinib mesylate) Drug Profile, 2025: TAGRISSO (osimertinib mesylate) drug patents, litigation, SPCs,

      osimertinibTAGRISSOmesylateDrug

      预订 TAGRISSO (osimertinib mesylate) Drug Profile, 2025: TAGRISSO (osimertinib mesylate) drug patents, litigation, SPCs,

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 CRESEMBA (isavuconazonium sulfate) Drug Profile, 2025: CRESEMBA (isavuconazonium sulfate) drug patents, SPCs, clini

      isavuconazoniumCRESEMBAsulfateDrug

      预订 CRESEMBA (isavuconazonium sulfate) Drug Profile, 2025: CRESEMBA (isavuconazonium sulfate) drug patents, SPCs, clini

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 DUETACT (glimepiride; pioglitazone hydrochloride) Drug Profile, 2025: DUETACT (glimepiride; pioglitazone hydrochlor

      pioglitazoneglimepirideDUETACThydrochloride

      预订 DUETACT (glimepiride; pioglitazone hydrochloride) Drug Profile, 2025: DUETACT (glimepiride; pioglitazone hydrochlor

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 DYANAVEL XR (amphetamine; amphetamine aspartate/dextroamphetamine sulfate) Drug Profile, 2025: amphetamine; ampheta

      amphetaminedextroamphetaminaspartate预订

      预订 DYANAVEL XR (amphetamine; amphetamine aspartate/dextroamphetamine sulfate) Drug Profile, 2025: amphetamine; ampheta

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 TIVICAY PD (dolutegravir sodium) Drug Profile, 2025: TIVICAY PD (dolutegravir sodium) drug patents, litigation, SPC

      dolutegravirTIVICAYsodiumDrug

      预订 TIVICAY PD (dolutegravir sodium) Drug Profile, 2025: TIVICAY PD (dolutegravir sodium) drug patents, litigation, SPC

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 BYFAVO (remimazolam besylate) Drug Profile, 2025: BYFAVO (remimazolam besylate) drug patents, clinical trials, drug

      remimazolambesylateDrugBYFAVO

      预订 BYFAVO (remimazolam besylate) Drug Profile, 2025: BYFAVO (remimazolam besylate) drug patents, clinical trials, drug

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 DUOBRII (halobetasol propionate; tazarotene) Drug Profile, 2025: DUOBRII (halobetasol propionate; tazarotene) drug

      halobetasolpropionatetazaroteneDUOBRII

      预订 DUOBRII (halobetasol propionate; tazarotene) Drug Profile, 2025: DUOBRII (halobetasol propionate; tazarotene) drug

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 EDARBI (azilsartan kamedoxomil) Drug Profile, 2025: EDARBI (azilsartan kamedoxomil) drug patents, litigation, SPCs,

      kamedoxomilazilsartanEDARBIDrug

      预订 EDARBI (azilsartan kamedoxomil) Drug Profile, 2025: EDARBI (azilsartan kamedoxomil) drug patents, litigation, SPCs,

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 COSELA (trilaciclib dihydrochloride) Drug Profile, 2025: COSELA (trilaciclib dihydrochloride) drug patents, litigat

      dihydrochloridetrilaciclibCOSELADrug

      预订 COSELA (trilaciclib dihydrochloride) Drug Profile, 2025: COSELA (trilaciclib dihydrochloride) drug patents, litigat

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 DYMISTA (azelastine hydrochloride; fluticasone propionate) Drug Profile, 2025: azelastine hydrochloride; fluticason

      hydrochlorideazelastinefluticasonepropionate

      预订 DYMISTA (azelastine hydrochloride; fluticasone propionate) Drug Profile, 2025: azelastine hydrochloride; fluticason

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 DUAVEE (bazedoxifene acetate; estrogens, conjugated) Drug Profile, 2025: DUAVEE (bazedoxifene acetate; estrogens, c

      bazedoxifeneestrogensacetateDUAVEE

      预订 DUAVEE (bazedoxifene acetate; estrogens, conjugated) Drug Profile, 2025: DUAVEE (bazedoxifene acetate; estrogens, c

      ¥3,045券后¥3,3450人已购买
      优惠券¥300 领券购买 
    • 预订 TIVICAY (dolutegravir sodium) Drug Profile, 2025: TIVICAY (dolutegravir sodium) drug patents, patent challenges, li

      dolutegravirTIVICAYsodiumDrug

      预订 TIVICAY (dolutegravir sodium) Drug Profile, 2025: TIVICAY (dolutegravir sodium) drug patents, patent challenges, li

      ¥3,045券后¥3,3450人已购买
      优惠券¥300 领券购买 
    • 预订 CLEVIPREX (clevidipine) Drug Profile, 2025: CLEVIPREX (clevidipine) drug patents, litigation, SPCs, clinical trials

      clevidipineCLEVIPREXDruglitigation

      预订 CLEVIPREX (clevidipine) Drug Profile, 2025: CLEVIPREX (clevidipine) drug patents, litigation, SPCs, clinical trials

      ¥3,049券后¥3,3490人已购买
      优惠券¥300 领券购买 
    • 预订 FARXIGA (dapagliflozin) Drug Profile, 2025: FARXIGA (dapagliflozin) drug patents, litigation, PTAB cases, SPCs, cli

      dapagliflozinFARXIGADruglitigation

      预订 FARXIGA (dapagliflozin) Drug Profile, 2025: FARXIGA (dapagliflozin) drug patents, litigation, PTAB cases, SPCs, cli

      ¥3,049券后¥3,3490人已购买
      优惠券¥300 领券购买 
    • 预订 DOVATO (dolutegravir sodium; lamivudine) Drug Profile, 2025: DOVATO (dolutegravir sodium; lamivudine) drug patents,

      dolutegravirlamivudineDOVATOsodium

      预订 DOVATO (dolutegravir sodium; lamivudine) Drug Profile, 2025: DOVATO (dolutegravir sodium; lamivudine) drug patents,

      ¥3,051券后¥3,3510人已购买
      优惠券¥300 领券购买 
    • 预订 STRIBILD (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate) Drug Profile, 2025: cobicistat; e

      cobicistatemtricitabineelvitegravirdisoproxil

      预订 STRIBILD (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate) Drug Profile, 2025: cobicistat; e

      ¥3,051券后¥3,3510人已购买
      优惠券¥300 领券购买 
    • 预订 CABENUVA KIT (cabotegravir; rilpivirine) Drug Profile, 2025: CABENUVA KIT (cabotegravir; rilpivirine) drug patents,

      cabotegravirrilpivirineCABENUVADrug

      预订 CABENUVA KIT (cabotegravir; rilpivirine) Drug Profile, 2025: CABENUVA KIT (cabotegravir; rilpivirine) drug patents,

      ¥3,052券后¥3,3520人已购买
      优惠券¥300 领券购买 
    • 预订 SYMBICORT (budesonide; formoterol fumarate dihydrate) Drug Profile, 2025: SYMBICORT (budesonide; formoterol fumarat

      budesonideformoterolSYMBICORTdihydrate

      预订 SYMBICORT (budesonide; formoterol fumarate dihydrate) Drug Profile, 2025: SYMBICORT (budesonide; formoterol fumarat

      ¥3,057券后¥3,3570人已购买
      优惠券¥300 领券购买 
    上一页 1 ...  16   17  18  19   20  下一页